Our mission is to advance our understanding in the cellular and molecular mechanisms of common and rare ocular diseases. Research in ocular pathobiology crosses a wide range of fields, including but not limited to inflammation, neurodegeneration, angiogenesis/vascular dysfunction, immunology, metabolism, ophthalmic imaging, machine learning, neuroprotection, gene therapy, stem cell biology, and regeneration. We aim to engage an active community of basic scientists and clinicians, to promote novel clinical, mechanistic, and translational research, to create a platform for exchange of ideas, development and strengthening of collaborations, dissemination of scientific knowledge, and to foster the growth of the next generation of ocular researchers through inspiring mentoring and education.
As a result of the aging of the world population and the increase in obesity and metabolic disorders, the prevalence of ocular diseases and associated visual impairment is rising rapidly. In the US alone, age-related macular degeneration affects close to 3 million people, > 2 million are diagnosed with glaucoma and > 6 million patients. These numbers are estimated to double or triple by 2050. In addition, there more than 250 inherited retinal disorders that constitute the most common cause of blindness for ages 20-45.
The objectives of the ASIP Ocular Pathobiology SIG are:
ASIP Members are invited to participate in the Ocular Pathobiology SIG Listserv. Please email firstname.lastname@example.org to have your name and email address added to the listserv.
To send a message to the Ocular Pathobiology SIG Listserv, send your email to email@example.com. Please note that you must be a member of this listserv in order to send and receive messages.
Please direct all questions to: Lisa McFadden (240) 283-9712.